Alvotech
Price & Volume
Stats
See more52W Range | $9.08-$18 |
Market Cap | $3.7B |
Shares Short | 79,013 |
Financials
See moreRevenue (12 Mos) | $308.7M |
Revenue Growth (YoY) | 4,399.7% |
Gross Profit (12 Mos) | $20.9M |
Diluted EPS | -$1.85 |
News
See moreYahoo Finance • 9 months ago
25 Countries with Highest Tax to GDP Ratio in the World
Yahoo Finance • 9 months ago
Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®
Yahoo Finance • 10 months ago
Is Alvotech (NASDAQ:ALVO) Trading At A 48% Discount?
About
CEO | Mr. Robert Wessman |
Address | 9, Rue de Bitbourg, Luxembourg City, Luxembourg, 1273 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 999 |
